Family Medicine · Cheboygan, MI
NPI
1548286222
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
740 S Main St
Cheboygan, MI, 49721
Phone (231) 627-1828
Groups this clinician bills Medicare through
Medicare paid, 2024
$263
18 services
Medicare patients, 2024
17
Average age 72
Drug cost, 2024
$926K
6,208 prescriptions
Company payments, 2025
$30.89
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Mark E Drogowski prescribed most often to Medicare patients was Rosuvastatin Calcium, with 238 prescriptions and refills. In total Mark E Drogowski wrote 6,208 Medicare prescriptions that cost $926K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 238 | 627 | 66 | $4,500 |
| Levothyroxine Sodium Generic | 233 | 582 | 52 | $3,033 |
| Atorvastatin Calcium Generic | 229 | 560 | 53 | $3,565 |
| Losartan Potassium Generic | 198 | 553 | 52 | $3,177 |
| Alprazolam Generic | 170 | 170 | 24 | $570 |
| Amlodipine Besylate Generic | 153 | 422 | 40 | $1,522 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 134 | 134 | 16 | $5,500 |
| Lisinopril Generic | 134 | 376 | 42 | $1,145 |
| Pantoprazole Sodium Generic | 130 | 324 | 34 | $2,302 |
| Omeprazole Generic | 128 | 336 | 37 | $1,643 |
| Gabapentin Generic | 120 | 144 | 20 | $1,467 |
| Meloxicam Generic | 114 | 185 | 29 | $705 |
| Metoprolol Succinate Generic | 112 | 311 | 29 | $2,335 |
| Hydrochlorothiazide Generic | 111 | 311 | 35 | $593 |
| Metformin Hcl Er Metformin Hcl | 105 | 274 | 28 | $1,756 |
Brand drugs: 835 claims; generic drugs: 5,341 claims; opioid claims: 270.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark E Drogowski $30.89 ($30.89 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $17.13.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.